Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and thromboxane b2

cetylpyridinium chloride anhydrous has been researched along with thromboxane b2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eriksson, AC; Hedbäck, B; Jonasson, L; Lindahl, TL; Whiss, PA1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and thromboxane b2

ArticleYear
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study.
    Journal of translational medicine, 2009, Jun-09, Volume: 7

    Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Cross-Over Studies; Female; Fibrinogen; Flow Cytometry; Health; Humans; Male; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Principal Component Analysis; Regression Analysis; Thromboxane B2; Ticlopidine

2009